Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") today announced that it has priced a public offering of $550,000,000 aggregate principal amount of 5.50% senior notes due 2035 ...
NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: MTSR) (“Metsera”), a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone (NuSH) analog ...